Greek pharma warns of innovative medicines ‘dead end’ amid global tensions
Speaking to Euractiv, Olympios Papadimitriou, President of SFEE, warns that pricing pressures and tariffs could deter companies from launching new medicines
News
Articles-Interviews-Speeches
Key challenges and strategic priorities for pharmaceutical policy in 2026
Address by the President of SFEE, Mr. Olympios Papadimitriou, at the Annual New Year’s Reception
Greek hospital drug funding crisis, pharma sector warns on patient access
Statement by Michael Himonas, General Manager of SFEE at Euractiv.com
Address of Mr. Olympios Papadimitriou, SFEE President, at New Year’s reception event
New Year’s reception event
Greece Healthcare & Life Sciences Review
Interview of Mr. Michael Himonas, General Manager of SFEE in pharmaboardroom.com
Pushing the boundaries of science for the benefit of patients
Blog post by Nathalie Moll to present an overview of the pipeline project
- 1
- 2
